Differential Cytokine mRNA Expression in Human Labial Minor Salivary Glands in Primary Sjögren's Syndrome

References

• Bloch K. J., Buchanan W. W., Wohl M. J., Bunim J. J. Sjögren's syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine 1965; 44: 187–231
   PubMed Web of Science ®Google Scholar
• Talal N., Moutsopoulos H. M., Kassan S. S. Sjögren's Syndrome: Clinical and immnunological aspects. Springer-Verlag, Berlin 1987; 1–295
   Google Scholar
• Skopouli F. N., Moutsopoulos H. M. Cytokines in Sjögren's syndrome. Ann. Med. Interne 1995; 146: 219–222
   PubMedGoogle Scholar
• O'Garra A. Interleukins and the immune system 1. Lancet 1989; i: 943–946
   Google Scholar
• O'Garra A. Interleukins and the immune system 2. Lancet 1989; i: 1003–1005
   Google Scholar
• Mountz J. D., Gausc W. C. Murine models of autoimmune disease and Sjögren's syndrome. Current Opin. Rheumatol. 1993; 5: 557–569
   PubMedGoogle Scholar
• Kapp A. The role of cytokines in psoriatic inflammation. Dermatol. Sci. 1993; 5: 133–142
   PubMedGoogle Scholar
• Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990; 33: 305–315
   PubMed Web of Science ®Google Scholar
• Feldmann M., Brennan F., Maini R. N. Role of cytokines in autoimmune disease. Clinical Applications of Cytokines. Role in Pathogenesis, Diagnosis, and Therapy, J. J. Oppenheim, J. L. Rossis, A. J.H. Gearing. Oxford Univ. Press, New York 1993; 109–113
   Google Scholar
• Fox P. C., Speight P. M. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome. Crit. Rev. Oral. Biol. Med. 1996; 7: 144–158
   PubMedGoogle Scholar
• Ogawa N., Dang H., Lazandis K., McGuff H. S., Aufdemorte T., Talal N. Analysis of transforming growth factor β and other cytokines in autoimmune exocrinopathy. J. Interferon Cytok. Res. 1995; 15: 759–767
   PubMedGoogle Scholar
• Ohyama Y., Nakamura S., Matsuzaki G., Shinohara M., Hiroki A., Fujimura T., Yamada A., Itoh K., Nomoto K. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 1996; 39: 1376–84
   PubMed Web of Science ®Google Scholar
• Fox R. I., Kang H., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J. Immunol. 1994; 152: 5532–5539
   PubMed Web of Science ®Google Scholar
• Greenspan J. S., Daniels T. E., Talal N., Sylvester R. A. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg. 1974; 37: 217–229
   PubMedGoogle Scholar
• Tarpley T. M., Anderson L. G., White C. L. Minor salivary gland involvement in Sjögren's syndrome. Oral Surg. 1974; 37: 64–74
   PubMedGoogle Scholar
• Emmert-Buck M., Roth M. J., Zhuang Z., Campo E., Rozhin J., Sloane B. F., Liotta L. A., Stetler-Stevenson W. G. Increased gelatinase A and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 1994; 145: 1285–1290
   PubMed Web of Science ®Google Scholar
• Krizman D. B., Chuaqui R. F., Meltzer P. S., Trent J. M., Duray P. H., Marston Linehan W., Liotta L. A., Emmert-Buck M. R. Construction of a representative cDNA library from prostatic intraepithelial neoplasia. Cancer Res. 1996; 56: 5380–5383
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Feinberg A. P., Vogelstein B. A technique for radio-labeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1984; 137: 266–267
   PubMed Web of Science ®Google Scholar
• Berchtold E., Martin W. A simple method for direct cloning and sequencing cDNA by the use of a single specific oligonucleotide and oligo(dT) in a polymerase chain reaction (PCR). Nucl. Acids Res. 1989; 17: 453
   PubMed Web of Science ®Google Scholar
• Noonan E., Roninson I. B. mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucl. Acids Res. 1988; 16: 10366–10367
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A laboratory manual. Cold Spring Harbor Laboratory. 1989
   Google Scholar
• Oxholm P., Daniels T. E., Bendtzen K. Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. Autoimmunity 1992; 12: 185–191
   PubMed Web of Science ®Google Scholar
• Boumba D., Skopouli F. N., Moutsopoulos H. M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Brit. J. Rheum. 1995; 34: 326–333
   PubMedGoogle Scholar
• Takai Y., Wong G. G., Clark S. C., Burakoff S. J., Herrman S. H. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J. Immunol. 1988; 140: 508–512
   PubMed Web of Science ®Google Scholar
• Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. Complementary DNA for novel human intcrleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73–76
   PubMed Web of Science ®Google Scholar
• Jourdan M., Bataille R., Seguin J., Zhang X. G., Chaplal P. A., Klein B. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum. 1990; 33: 398–402
   PubMed Web of Science ®Google Scholar
• Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., Sato K., Shimizu M., Maini R., Feldman M., Kishimoto T. Excessive production of interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 1988; 18: 1797–1801
   PubMed Web of Science ®Google Scholar
• Houssiau F. A., Devogel J. P., Van Damme J., De Deuxchaisnes C. N., Van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1988; 31: 784–788
   PubMed Web of Science ®Google Scholar
• Bhardwaj N., Santhanam U., Lau L. L., Tatter S. B., Ghrayeb J., Rivelis M., Steinman R. M., Sehgal P. B., May L. T. IL-6/IFN-β-2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J. Immunol. 1989; 143: 2153–2159
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Buschard K., Diamant M., Horn T., Svenson M. Possible role of IL-1, TNF-α, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Lymphakine Res. 1989; 8: 335–340
   PubMedGoogle Scholar
• Campbell I. L., Cutri A., Wilson A., Harrison L. C. Evidence for IL-6 production by and effects on the pancreatic beta-cell. J. Immunol. 1989; 143: 1188–1191
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Harrison C. A new view of the beta cell as an antigen-presenting cell and immunogenic target. J. Autoimmun. 1990; 3: 53–62
   PubMedGoogle Scholar
• Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tagoh H., Komori T., Kishimoto S., Hirano T., Kishimoto T. Pathological significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360–1367
   PubMed Web of Science ®Google Scholar
• Grisius M. M., Bermudez D. K., Fox P. C. Salivary and serum interleukin 6 in primary Sjögren's syndrome. J. Rheumatol. 1997; 24: 1089–1091
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Moore K. W. The role of IL-10 in crossregulation of Thl and Th2 responses. Immunol. Today 1991; 12: A49
   PubMedGoogle Scholar
• Kim J., Modlin R. L., Moy R. L., Dubinett S. M., McHugh T., Nickoloff B. J., Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 1995; 155: 2240–2247
   PubMed Web of Science ®Google Scholar
• Fox R. I., Bumol T., F'antozzi R., Bone R., Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis. Rheum. 1986; 29: 1105
   PubMed Web of Science ®Google Scholar
• Brookes S. M., Price E. J., Venables P. J.W., Maini R. N. Inlerferon-gamma and epithelial cell activation in Sjögren's syndrome. Brit. J. Rheumat. 1995; 34: 226–231
   PubMedGoogle Scholar
• Merrill J. E., Kono D. H., Clayton J., Ando D. G., Hinton D. R., Hoffman F. M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 1992; 89: 574–578
   PubMed Web of Science ®Google Scholar
• Campbell I. L., Kay T. W.H., Oxbrow L., Harrison L. C. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 1991; 87: 739–742
   PubMed Web of Science ®Google Scholar
• Tc Velde A. A., Huijbens R. J.F., Heije K., Devries J. E., Figdor C. G. Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor-α, and IL-6 by human monocyte. Blood 1990; 76: 1392–1397
   PubMedGoogle Scholar
• Suzuki H., Sugiyama E., Tunru I., Yamashita N., Matsuno H., Hamazaki T., Kobayashi M. Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells. Clin. Immunol. Immunopathol. 1993; 66: 67–72
   PubMedGoogle Scholar
• Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Cyopick P., Danska J. S., Delovitch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 1993; 178: 87–99
   PubMed Web of Science ®Google Scholar
• Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor-a, interleukin 1, and prostaglandin E2. Proc. Natl. Acad. Sci. USA 1989; 86: 3803–3807
   PubMed Web of Science ®Google Scholar
• Santambrogio L., Hochwald G. M., Saxena B., Leu C. -H., Martz J. E., Carlino J. A., Ruddle N. H., Palladino M. A., Gold L. T., Thorbecke G. J. Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J. Immunol. 1993; 151: 1116–1127
   PubMed Web of Science ®Google Scholar
• Kizu Y., Sakurai S., Katagiri S., Shinozaki N., Ono M., Tsubota K., Saito I. Immunohistological analysis of tumor growth factor β1 expression in normal and inflamed salivary glands. J. Clin. Pathol. 1996; 49: 728
   PubMed Web of Science ®Google Scholar
• Scully C., El-Kom M. Lichen planus: Review and update on pathogenesis. J. Oral Pathol. 1985; 14: 431–458
   PubMedGoogle Scholar
• Rapoport B. Pathophysiology of Hashimoto's thyroiditis and hypothyroidism. Annu. Rev. Med. 1991; 42: 91
   PubMedGoogle Scholar
• Rosenberg A., Singer A. Cellular basis of skin allograft rejection: An in vivo model of immune-mediated destruction. Annu. Rev. Immunol. 1992; 10: 333
   PubMed Web of Science ®Google Scholar